Drug (ID: DG01848) and It's Reported Resistant Information
Name
Interferon alfa-2B
Synonyms
INTERFERON ALFA-2B; 98530-12-2; Interferon alfa-2b, recombinant; C16H17Cl3I2N3NaO5S; SCHEMBL6041041; K779; Q4391540
    Click to Show/Hide
Indication
In total 1 Indication(s)
Melanoma [ICD-11: 2C30]
Approved
[1]
Structure
Drug Resistance Disease(s)
Disease(s) with Clinically Reported Resistance for This Drug (1 diseases)
Head and neck cancer [ICD-11: 2D42]
[1]
Target Interferon-alpha 2 (IFNA2) IFNA2_HUMAN [1]
Click to Show/Hide the Molecular Information and External Link(s) of This Drug
Formula
7
IsoSMILES
CCCN(CCOC1=C(C=C(C=C1Cl)Cl)Cl)C(=O)N2C=CN=C2.C(S(=O)(=O)[O-])(I)I.[Na+]
InChI
InChI=1S/C15H16Cl3N3O2.CH2I2O3S.Na/c1-2-4-20(15(22)21-5-3-19-10-21)6-7-23-14-12(17)8-11(16)9-13(14)18;2-1(3)7(4,5)6;/h3,5,8-10H,2,4,6-7H2,1H3;1H,(H,4,5,6);/q;;+1/p-1
InChIKey
MIXCUJKCXRNYFM-UHFFFAOYSA-M
PubChem CID
71306834
TTD Drug ID
D0P0WV
DrugBank ID
DB05258
Type(s) of Resistant Mechanism of This Drug
  EADR: Epigenetic Alteration of DNA, RNA or Protein
Drug Resistance Data Categorized by Their Corresponding Diseases
ICD-02: Benign/in-situ/malignant neoplasm
Click to Show/Hide the Resistance Disease of This Class
Head and neck cancer [ICD-11: 2D42]
Click to Show/Hide
Drug Resistance Data Categorized by Their Corresponding Mechanisms
       Epigenetic Alteration of DNA, RNA or Protein (EADR) Click to Show/Hide
Key Molecule: MX dynamin like GTPase 1 (MX1) [1]
Molecule Alteration Up-regulation
Interaction
Resistant Disease Head and neck squamous cell carcinoma [ICD-11: 2D42.1]
Experimental Note Identified from the Human Clinical Data
In Vitro Model HN30 cells Nasopharyngeal Homo sapiens (Human) CVCL_5525
HN4 cells Nasopharyngeal Homo sapiens (Human) CVCL_IS30
HN6 cells Tongue Homo sapiens (Human) CVCL_8129
In Vivo Model BALB/c nude mice model Mus musculus
Experiment for
Molecule Alteration
Overexpression assay
Experiment for
Drug Resistance
Flow cytometry assay
Mechanism Description LncMX1-215 negatively regulates immunosuppression by interrupting GCN5/H3K27ac binding in HNSCC.
References
Ref 1 A novel IFNAlpha-induced long noncoding RNA negatively regulates immunosuppression by interrupting H3K27 acetylation in head and neck squamous cell carcinomaMol Cancer. 2020 Jan 6;19(1):4. doi: 10.1186/s12943-019-1123-y.

If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.